Stem cells in neurodegeneration and injury

Tissue Stem Cells

Volumn , Issue , 2006, Pages 271-304

  Vawda, Reaz ^a   Kennea, Nigel L ^a   Mehmet, Huseyin ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80955131994     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (278)

1. Steindler DA. Glial boundaries in the developing nervous system. Annu Rev Neurosci 1993; 16:445-470.
2. Schwab ME., Kapfhammer JP, Bandtlow CE. Inhibitors of neurite growth. Annu Rev Neurosci 1993; 16:565-595.
3. Lindvall O et al. Grafts of Fetal Dopamine Neurones Survive & Improve Motor Function in Parkinson’s Disease. Science 1990; 247:574-577.
4. Deacon T et al. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson’s disease. Nat Med 1997; 3(3):350-353.
5. Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med (Maywood) 2001; 226(6):507-520.
6. Pesce M, Gross MK, Scholer HR. In line with our ancestors: Oct-4 and the mammalian germ. Bioessays 1998; 20(9):722-732.
7. Pesce, M et al. Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation. Mech Dev 1998; 71(1-2):89-98.
8. Solter D, Knowles BB. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci USA 1978; 75(11):5565-5569.
9. Gooi HC et al. Stage-specific embryonic antigen involves alpha 1 goes to 3 fucosylated type 2 blood group chains. Nature 1981; 292(5819):156-158.
10. Andrews PW et al. Two monoclonal antibodies recognizing determinants on human embryonal carcinoma cells react specifically with the liver isozyme of human alkaline phosphatase. Hybridoma 1984; 3(1):33-39.
11. Andrews PW et al. Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. Hybridoma 1984; 3(4):347-361.
12. Zhou S et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001; 7(9):1028-1034.
13. Murphy M, Drago J, Bartlett PF. Fibroblast growth factor stimulates the proliferation and differentiation of neural precursor cells in vitro. J Neurosci Res 1990; 25(4):463-475.
14. Reynolds BA, Weiss S. Generation of neurones and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992; 255:1707-1710.
15. Gage FH. Mammalian neural stem cells. Science 2000; 287(5457):1433-1438.
16. Roufosse CA et al. Circulating mesenchymal stem cells. Int J Biochem Cell Biol 2004; 36(4):585-597.
17. Thomson JA et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282(5391):1145-1147.
18. Bain G et al. Embryonic stem cells express neuronal properties in vitro. Dev Biol 1995; 168(2):342-357.
19. Brustle O et al. In vitro-generated neural precursors participate in mammalian brain development. Proc Natl Acad Sci USA 1997; 94(26):14809-14814.
20. Carpenter MK et al. Enrichment of neurones and neural precursors from human embryonic stem cells. Exp Neurol 2001; 172(2):383-397.
21. Svendsen CN, Caldwell MA, Ostenfeld T. Human neural stem cells: isolation, expansion and transplantation. Brain Pathol 1999; 9(3):499-513.
22. McKay R. Stem cells in the central nervous system. Science 1997; 276:66-71.
23. Temple S, Alvarez-Buylla A. Stem cells in the adult mammalian central nervous system. Curr Opin Neurobiol 1999; 9(1):135-141.
24. Carpenter MK et al. In vitro expansion of a multipotent population of human neural progenitor cells. Exp Neurol 1999; 158(2):265-278.
25. Piper DR et al. Identification and characterization of neuronal precursors and their progeny from human fetal tissue. J Neurosci Res 2001; 66(3):356-358.
26. Uchida N et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 2000; 97(26):14720-14725.
27. Ginis I, Rao MS. Toward cell replacement therapy: promises and caveats. Exp Neurol 2003; 184(1):61-77.
28. Palmer TD et al. Cell culture. Progenitor cells from human brain after death. Nature 2001; 411(6833):42-43.
29. Tohyama T et al. Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells. Lab Invest 1992; 66(3):303-313.
30. Lendahl U, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell 1990; 60(4):585-595.
31. Lin RC et al. Re-expression of the intermediate filament nestin in reactive astrocytes. Neurobiol Dis 1995; 2(2):79-85.
32. Sakakibara S et al. Mouse-Musashi-1, a neural RNA-Binding protein highly enriched in the mammalian CNS stem cell. Dev Biol 1996; 176(2):230-242.
33. Okano H, Imai T, Okabe M. Musashi: a translational regulator of cell fate. J Cell Sci 2002: 115(Pt 7):1355-1359.
34. Allen T, Lobe CG. A comparison of Notch, Hes and Grg expression during murine embryonic and post-natal development. Cell Mol Biol 1999; 45(5):687-708.
35. Graham GJ, Wright EG. Haemopoietic stem cells: their heterogeneity and regulation. Int J Exp Pathol 1997; 78(4):197-218.
36. Vescovi AL, Snyder EY. Establishment and properties of neural stem cell clones: plasticity in vitro and in vivo. Brain Pathol 1999; 9(3):569-598.
37. Modo M et al. Tracking transplanted stem cell migration using bifunctional, contrast agentenhanced, magnetic resonance imaging. Neuroimage 2002; 17(2):803-811.
38. Ostenfeld T et al. Regional specification of rodent and human neurospheres. Brain Res Dev Brain Res 2002; 134(1-2):43-55.
39. Morrison SJ. Neuronal potential and lineage determination by neural stem cells. Curr Opin Cell Biol 2001; 13(6):666-672.
40. Morrison SJ. Neuronal differentiation: proneural genes inhibit gliogenesis. Curr Biol 2001; 11(9):R349-R351.
41. MayerProschel M et al. Isolation of lineage-restricted neuronal precursors from multipotent neuroepithelial stem cells. Neuron 1997; 19(4):773-785.
42. Rao MS. Multipotent and restricted precursors in the central nervous system. Anat Rec 1999; 257(4):137-148.
43. Cameron HA, McKay R. Discussion point—stem cells and neurogenesis in the adult brain. Curr Opin Neurobiol 1998; 8(5):677-680.
44. Kukekov VG et al. A nestin-negative precursor cell from the adult mouse brain gives rise to neurones and glia. Glia 1997; 21(4):399-407.
45. Lillien L. Neural progenitors and stem cells: mechanisms of progenitor heterogeneity. Curr Opin Neurobiol 1998; 8(1):37-44.
46. Lillien L, Wancio D. Changes in epidermal growth factor receptor expression and competence to generate glia regulate timing and choice of differentiation in the retina. Mol Cell Neurosci 1998; 10(5-6):296-308.
47. Burrows RC et al. Response, diversity and the timing of progenitor cell maturation are regulated by developmental changes in EGFR expression in the cortex. Neuron 1997; 19(2):251-267.
48. Tropepe V et al. Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. Dev Biol 1999; 208(1):166-188.
49. Meletis K, Frisen J. Blood on the tracks: a simple twist of fate? Trends Neurosci 2003; 26(6):292-296.
50. Howell JC et al. Pluripotent stem cells identified in multiple murine tissues. Ann N Y Acad Sci 2003; 996:158-173.
51. Sanchez-Ramos JR. Neural cells derived from adult bone marrow and umbilical cord blood. J Neurosci Res 2002; 69(6):880-893.
52. Abuljadayel IS. Induction of stem cell-like plasticity in mononuclear cells derived from unmobilised adult human peripheral blood. Curr Med Res Opin 2003; 19(5):355-375.
53. Milhaud, G. A human pluripotent stem cell in the blood of adults: towards a new cellular therapy for tissue repair. Bull Acad Natl Med 2001; 185(3):567-577; discussion 577-582.
54. Zhao Y, Glesne D, Huberman E. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci USA 2003; 100(5):2426-2431.
55. Ha Y et al. Intermediate filament nestin expressions in human cord blood monocytes (HCMNCs). Acta Neurochir (Wien) 2003; 145(6):483-487.
56. Ha Y et al. Neural phenotype expression of cultured human cord blood cells in vitro. Neuroreport 2001; 12(16):3523-3527.
57. Lee OK et al. Isolation of multi-potent mesenchymal stem cells from umbilical cord blood. Blood 2003; 103(5):1669-1675.
58. Mitchell KE et al. Matrix cells from Wharton’s jelly form neurones and glia. Stem Cells 2003; 21(1):50-60.
59. Weiss ML et al. Transplantation of porcine umbilical cord matrix cells into the rat brain. Exp Neurol 2003; 182(2):288-299.
60. In’t Anker PS et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003; 102(4):1548-1549.
61. In’t Anker PS et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004; 22(7):1338-1345.
62. Condorelli G et al. Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc Natl Acad Sci USA 2001; 98(19):10733-10738.
63. Frid MG, Kale VA, Stenmark KR. Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. Circ Res 2002; 90(11):1189-1196.
64. Ashjian PH et al. In vitro differentiation of human processed lipoaspirate cells into early neural progenitors. Plast Reconstr Surg 2003; 111(6):1922-1931.
65. Tholpady SS, Katz AJ, Ogle RC. Mesenchymal stem cells from rat visceral fat exhibit multipotential differentiation in vitro. Anat Rec 2003; 272A(1):398-402.
66. Jay KE, Gallacher L, Bhatia M. Emergence of muscle and neural hematopoiesis in humans. Blood 2002; 100(9):3193-3202.
67. Mahmud N et al. Primate skeletal muscle contains cells capable of sustaining in vitro hematopoiesis. Exp Hematol 2002; 30(8):925-936.
68. Deng J et al. Neural trans-differentiation potential of hepatic oval cells in the neonatal mouse brain. Exp Neurol 2003; 182(2):373-382.
69. Gronthos S et al. Stem cell properties of human dental pulp stem cells. J Dent Res 2002; 81(8):531-535.
70. Liang L, Bickenbach JR. Somatic epidermal stem cells can produce multiple cell lineages during development. Stem Cells 2002; 20(1):21-31.
71. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276(5309):71-74.
72. Scheffler B et al. Marrow-mindedness: a perspective on neuropoiesis. Trends Neurosci 1999; 22(8):348-357.
73. Tao H, Ma DD. Evidence for transdifferentiation of human bone marrow-derived stem cells: recent progress and controversies. Pathology 2003; 35(1):6-13.
74. Bruder SP, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 1994; 56(3):283-294.
75. Caplan AI. The mesengenic process. Clin Plast Surg 1994; 21(3):429-435.
76. Lodie TA et al. Systematic analysis of reportedly distinct populations of multipotent bone marrow-derived stem cells reveals a lack of distinction. Tissue Eng 2002; 8(5):739-754.
77. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970; 3(4):393-403.
78. Friedenstein AJ et al. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 1974; 17(4):331-340.
79. Friedenstein AJ et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 1974; 2(2):83-92.
80. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976; 4(5):267-274.
81. Friedenstein AJ. Stromal mechanisms of bone marrow: cloning in vitro and retransplantation in vivo. Hamatol Bluttransfus 1980; 25:19-29.
82. Friedenstein AJ et al. Marrow microenvironment transfer by heterotopic transplantation of freshly isolated and cultured cells in porous sponges. Exp Hematol 1982; 10(2):217-227.
83. Friedenstein AJ, Chailakhyan RK, Gerasimov UV. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 1987; 20(3):263-272.
84. Kuznetsov SA, Friedenstein AJ, Robey PG. Factors required for bone marrow stromal fibroblast colony formation in vitro. Br J Haematol 1997; 97(3):561-570.
85. Luria EA, Panasyuk AF, Friedenstein AY. Fibroblast colony formation from monolayer cultures of blood cells. Transfusion 1971; 11(6):345-349.
86. Kassem M, Kristiansen M, Abdallah BM. Mesenchymal stem cells: cell biology and potential use in therapy. Basic Clin Pharmacol Toxicol 2004; 95(5):209-214.
87. Krebsbach PH et al. Bone marrow stromal cells: characterization and clinical application. Crit Rev Oral Biol Med 1999; 10(2):165-181.
88. Jiang Y et al. Neuroectodermal differentiation from mouse multipotent adult progenitor cells. Proc Natl Acad Sci USA 2003; 100(1):11854-11860.
89. Hung SC et al. In vitro differentiation of size-sieved stem cells into electrically active neural cells. Stem Cells 2002; 20(6):522-529.
90. Kohyama J et al. Brain from bone: efficient “meta-differentiation” of marrow stroma-derived mature osteoblasts to neurones with Noggin or a demethylating agent. Differentiation 2001; 68(4-5):235-244.
91. Speert H. Obstetric-gynecologic eponyms; Thomas Wharton and the jelly of the umbilical cord. Obstet Gynecol 1956; 8(3):380-382.
92. Kobayashi K, Kubota T, Aso T. Study on myofibroblast differentiation in the stromal cells of Wharton’s jelly: expression and localization of alpha-smooth muscle actin. Early Hum Dev 1998; 51(3):223-233.
93. Quesenberry PJ et al. Correlates between hematopoiesis and neuropoiesis: neural stem cells. J Neurotrauma 1999; 16(8):661-666.
94. Weissman IL. Stem cells—lessons from hematopoieses. In Gage F, Christen Y, eds. Isolation, Characterisation & Utilisation of CNS Stem Cells. Berlin, Heidelberg: Spring Verlag, 1997:1-8.
95. Morrison SJ. The last shall not be first: the ordered generation of progeny from stem cells. Neuron 2000; 28(1):1-3.
96. Gardner LJ et al. Identification of CD56 and CD57 by flow cytometry in Ewing’s sarcoma or primitive neuroectodermal tumor. Virchows Arch 1998; 433(1):35-40.
97. Chung DH et al. ILK (beta1-integrin-linked protein kinase): a novel immunohistochemical marker for Ewing’s sarcoma and primitive neuroectodermal tumour. Virchows Arch 1998; 433(2):113-117.
98. Sugimoto T, Umezawa A, Hata J. Neurogenic potential of Ewing’s sarcoma cells. Virchows Arch 1997; 430(1):41-46.
99. Bjornson CR et al. Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 1999; 283(5401):534-537.
100. Galli R et al. Skeletal myogenic potential of human and mouse neural stem cells. Nat Neurosci 2000; 3(10):986-991.
101. Rietze RL et al. Purification of a pluripotent neural stem cell from the adult mouse brain. Nature 2001; 412(6848):736-739.
102. Vescovi A et al. Neural stem cells: plasticity and their transdifferentiation potential. Cells Tissues Organs 2002; 171(1):64-76.
103. Mezey E, Chandross KJ. Bone marrow: a possible alternative source of cells in the adult nervous system. Eur J Pharmacol 2000; 405(1-3):297-302.
104. Lu P, Blesch A, Tuszynski MH. Induction of bone marrow stromal cells to neurones: differentiation, transdifferentiation, or artifact? J Neurosci Res 2004; 77(2):174-191.
105. Brazelton TR et al. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 2000; 290(5497):1775-1779.
106. Mezey E et al. Comment on failure of bone marrow cells to transdifferentiate into neural cells in vivo. Science 2003; 299(5610):1184; author reply 1184.
107. Mezey E et al. Transplanted bone marrow generates new neurones in human brains. Proc Natl Acad Sci USA 2003; 100(3):1364-1369.
108. Weimann JM et al. Contribution of transplanted bone marrow cells to Purkinje neurones in human adult brains. Proc Natl Acad Sci USA 2003; 100(4):2088-2093.
109. Cogle CR et al. Bone marrow transdifferentiation in brain after transplantation: a retrospective study. Lancet 2004; 363(9419):1432-1437.
110. Khosrotehrani K, Bianchi DW. Multi-lineage potential of fetal cells in maternal tissue: a legacy in reverse. J Cell Sci 2005; 118(Pt 8):1559-1563.
111. Woodbury D et al. Adult rat and human bone marrow stromal cells differentiate into neurones. J Neurosci Res 2000; 61(4):364-370.
112. Buzanska L et al. Human cord blood-derived cells attain neuronal and glial features in vitro. J Cell Sci 2002; 115(Pt 10):2131-2138.
113. Vogel W et al. Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells. Haematologica 2003; 88(2):126-133.
114. Donnelly DS, Krause DS. Hematopoietic stem cells can be CD34+ or CD342. Leuk Lymphoma 2001; 40(3-4):221-234.
115. Bonilla S et al. Haematopoietic progenitor cells from adult bone marrow differentiate into cells that express oligodendroglial antigens in the neonatal mouse brain. Eur J Neurosci 2002; 15(3):575-582.
116. Hao HN et al. Fetal human hematopoietic stem cells can differentiate sequentially into neural stem cells and then astrocytes in vitro. J Hematother Stem Cell Res 2003; 12(1):23-32.
117. Goolsby J et al. Hematopoietic progenitors express neural genes. Proc Natl Acad Sci USA 2003; 100(25):14926-14931.
118. Krause DS et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001; 105(3):369-377.
119. Terada N et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002; 416(6880):542-545.
120. Ying QL et al. Changing potency by spontaneous fusion. Nature 2002; 416(6880):545-548.
121. Anderson DJ, Gage FH, Weissman IL. Can stem cells cross lineage boundaries? Nat Med 2001; 7(4):393-395.
122. Morshead CM et al. Hematopoietic competence is a rare property of neural stem cells that may depend on genetic and epigenetic alterations. Nat Med 2002; 8(3):268-273.
123. Alvarez-Dolado M et al. Fusion of bone-marrow-derived cells with Purkinje neurones, cardiomyocytes and hepatocytes. Nature 2003; 425(6961):968-973.
124. Black IB, Woodbury D. Adult rat and human bone marrow stromal stem cells differentiate into neurones. Blood Cells Mol Dis 2001; 27(3):632-636.
125. Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 2004; 36(4):568-584.
126. McKinney-Freeman SL et al. Muscle-derived hematopoietic stem cells are hematopoietic in origin. Proc Natl Acad Sci USA 2002; 99(3):1341-1346.
127. Zhao LR et al. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol 2002; 174(1):11-20.
128. Wells WA. Is transdifferentiation in trouble? J Cell Biol 2002; 157(1):15-18.
129. Labat ML. Stem cells and the promise of eternal youth: embryonic versus adult stem cells. Biomed Pharmacother 2001; 55(4):179-185.
130. Herzog EL, Chai L, Krause DS. Plasticity of marrow derived stem cells. Blood 2003; 102(10): 3483-3493.
131. Reubinoff BE et al. Neural progenitors from human embryonic stem cells. Nat Biotechnol 2001; 19(12):1134-1140.
132. Zhang SC et al. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 2001; 19(12):1129-1133.
133. Flax JD et al. Engraftable human neural stem cells respond to developmental cues, replace neurones, and express foreign genes. Nat Biotechnol 1998; 16(11):1033-1039.
134. Svendsen CN et al. Survival and differentiation of rat and human epidermal growth factorresponsive precursor cells following grafting into the lesioned adult central nervous system. Exp Neurol 1996; 137(2):376-388.
135. McDonald JW et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 1999; 5(12):1410-1412.
136. Brustle O et al. Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science 1999; 285(5428):754-756.
137. Liu S et al. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci USA 2000; 97(11):6126-6131.
138. Snyder EY et al. Multipotent neural precursors can differentiate toward replacement of neurones undergoing targeted apoptotic degeneration in adult mouse neocortex. Proc Nat Acad Sci USA 1997; 94(21):11663-11668.
139. Ourednik V et al. Segregation of human neural stem cells in the developing primate forebrain. Science 2001; 293(5536):1820-1824.
140. Englund U et al. Transplantation of human neural progenitor cells into the neonatal rat brain: extensive migration and differentiation with long-distance axonal projections. Exp Neurol 2002; 173(1):1-21.
141. Englund U, Bjorklund A, Wictorin K. Migration patterns and phenotypic differentiation of long-term expanded human neural progenitor cells after transplantation into the adult rat brain. Brain Res Dev Brain Res 2002; 134(1-2):123-141.
142. Clarke DL et al. Generalized potential of adult neural stem cells. Science 2000; 288(5471):1660-1663.
143. Carlen M et al. Functional integration of adult-born neurones. Curr Biol 2002; 12(7):606-608.
144. Chu K et al. Human neural stem cells can migrate, differentiate, and integrate after intravenous transplantation in adult rats with transient forebrain ischemia. Neurosci Lett 2003; 343(2):129-133.
145. Eglitis MA, Mezey E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci USA 1997; 94(8):4080-4085.
146. Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 2003; 5(6):485-489.
147. Le Blanc K et al. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003; 31(10):890-896.
148. Hori J et al. Neural progenitor cells lack immunogenicity and resist destruction as allografts. Stem Cells 2003; 21(4):405-416.
149. Armstrong RJ et al. Transplantation of expanded neural precursor cells from the developing pig ventral mesencephalon in a rat model of Parkinson’s disease. Exp Brain Res 2003; 151(2):204-217.
150. Ortiz LA et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 2003; 100(14):8407-8411.
151. Magrassi L et al. Freshly dissociated fetal neural stem/progenitor cells do not turn into blood. Mol Cell Neurosci 2003; 22(2):179-187.
152. Magrassi L. Differences and similarities among phenotypes of mesenchymal and neural stem cells. Haematologica 2003; 88(2):121.
153. Kicic A et al. Differentiation of marrow stromal cells into photoreceptors in the rat eye. J Neurosci 2003; 23(21):7742-7749.
154. Lewis ID, Verfaillie CM. Multi-lineage expansion potential of primitive hematopoietic progenitors: superiority of umbilical cord blood compared to mobilized peripheral blood. Exp Hematol 2000; 28(9):1087-1095.
155. Bonnet, pers. commun., Nov. 2003.
156. Zheng T, Steindler DA, Laywell ED. Transplantation of an indigenous neural stem cell population leading to hyperplasia and atypical integration. Cloning Stem Cells 2002; 4(1):3-8.
157. Mehmet, pers. commun., Nov. 2003
158. Keene CD et al. Neural differentiation and incorporation of bone marrow-derived multipotent adult progenitor cells after single cell transplantation into blastocyst stage mouse embryos. Cell Transplant 2003; 12(3):201-213.
159. Rossi F, Cattaneo E. Opinion: neural stem cell therapy for neurological diseases: dreams and reality. Nat Rev Neurosci 2002; 3(5):401-409.
160. Fearnley JM, Lees AJ. Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain 1991; 114(Pt 5):2283-2301.
161. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson’s disease. Pathophysiologic and clinical implications. N Engl J Med 1988; 318(14):876-880.
162. Zhang J et al. Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol 2005; 195(1):16-26.
163. Lescaudron L, Unni D, Dunbar GL. Autologous adult bone marrow stem cell transplantation in an animal model of huntington’s disease: behavioral and morphological outcomes. Int J Neurosci 2003; 113(7):945-956.
164. Cheng L et al. Human adult marrow cells support prolonged expansion of human embryonic stem cells in culture. Stem Cells 2003; 21(2):131-142.
165. Samii A, Nutt JG, Ransom BR. Parkinson’s disease. Lancet 2004; 363(9423):1783-1793.
166. Freed CR et al. Transplantation of embryonic dopamine neurones for severe Parkinson’s disease. N Engl J Med 2001; 344(10):710-719.
167. Studer L, Tabar V, McKay RDG. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat Neurosci 1998; 1(4):290-295.
168. Laywell ED, Kukekov VG, Steindler DA. Multipotent neurospheres can be derived from forebrain subependymal zone and spinal cord of adult mice after protracted postmortem intervals. Experimental Neurology 1999; 156(2):430-433.
169. Svendsen CN et al. Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson’s disease. Experimental Neurology 1997; 148(1):135-146.
170. Weiss S. Pathways for Neural Stem Cell Biology & Repair., in Nature. 1999:850-851.
171. Fricker RA et al. Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain. J Neurosci 1999; 19(14):5990-6005.
172. Sawamoto K et al. Generation of dopaminergic neurones in the adult brain from mesencephalic precursor cells labeled with a nestin-GFP transgene. J Neurosci 2001; 21(11):3895-3903.
173. Kim JH et al. Dopamine neurones derived from embryonic stem cells function in an animal model of Parkinson’s disease. Nature 2002; 418(6893):50-56.
174. Crossman AR. Functional anatomy of movement disorders. J Anat 2000; 196(Pt 4): 519-525.
175. Crossman AR. Primate models of dyskinesia: the experimental approach to the study of basal ganglia-related involuntary movement disorders. Neuroscience 1987; 21(1):1-40.
176. Isacson O, Breakefield XO. Benefits and risks of hosting animal cells in the human brain. Nat Med 1997; 3(9):964-969.
177. Philpott LM et al. Neuropsychological functioning following fetal striatal transplantation in Huntington’s chorea: three case presentations. Cell Transplant 1997; 6(3):203-212.
178. Armstrong RJ et al. Survival, neuronal differentiation, and fiber outgrowth of propagated human neural precursor grafts in an animal model of Huntington’s disease. Cell Transplant 2000; 9(1):55-64.
179. Warlow C et al. Stroke. Lancet 2003; 362(9391):1211-1224.
180. Azzopardi D et al. Pilot study of treatment with whole body hypothermia for neonatal encephalopathy. Pediatrics 2000; 106(4):684-694.
181. Hill MD, Hachinski V. Stroke treatment: time is brain. Lancet 1998; 352(Suppl 3): SIII10-SIII14.
182. Gluckman PD et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 2005; 365(9460):663-670.
183. Sorensen JC et al. Fetal neocortical tissue blocks implanted in brain infarcts of adult rats interconnect with the host brain. Exp Neurol 1996; 138(2):227-235.
184. Hodges H et al. Contrasting effects of fetal CA1 and CA3 hippocampal grafts on deficits in spatial learning and working memory induced by global cerebral ischaemia in rats. Neuroscience 1996; 72(4):959-988.
185. Chopp M, Li Y. Treatment of neural injury with marrow stromal cells. Lancet Neurol 2002; 1(2):92-100.
186. Chopp M, Li Y. Treatment of stroke with marrow stromal cells. International Congress Series 2003; 1252:465-470.
187. Chen J et al. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 2003; 73(6):778-786.
188. Chen J et al. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci 2001; 189(1-2):49-57.
189. Chen J et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001; 32(4):1005-1011.
190. Chen J et al. Combination therapy of stroke in rats with a nitric oxide donor and human bone marrow stromal cells enhances angiogenesis and neurogenesis. Brain Res 2004; 1005(1-2):21-28.
191. Chen J et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001; 32(11):2682-2688.
192. Chen J et al. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res 2003; 92(6):692-699.
193. Li Y et al. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 2002; 59(4):514-523.
194. Li Y, Chen, J, Chopp, M. Adult bone marrow transplantation after stroke in adult rats. Cell Transplant 2001; 10(1):31-40.
195. Li Y et al. Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 2001; 56(12):1666-1672.
196. Li Y et al. Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab 2000; 20(9):1311-1319.
197. Li Y et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 2004; 49(3):407-417.
198. Okano H et al. Transplantation of neural stem cells into the spinal cord after injury. Semin Cell Dev Biol 2003; 14(3):191-198.
199. Shear DA et al. Neural progenitor cell transplants promote long-term functional recovery after traumatic brain injury. Brain Res 2004; 1026(1):11-22.
200. Lu D et al. Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome. Neuroreport 2001; 12(3):559-563.
201. Chopp M et al. Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport 2000; 11(13):3001-3005.
202. Compston A, Coles A. Multiple sclerosis. Lancet 2002; 359(9313):1221-1231.
203. Hall GL, Compston A, Scolding NJ. Beta-interferon and multiple sclerosis. Trends Neurosci 1997; 20(2):63-67.
204. Scolding N et al. Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain 1998; 121(Pt 12):2221-2228.
205. Wolswijk G. Oligodendrocyte regeneration in the adult rodent CNS and the failure of this process in multiple sclerosis. Prog Brain Res 1998; 117:233-247.
206. Chang A et al. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 2002; 346(3):165-173.
207. Kohama I et al. Transplantation of cryopreserved adult human Schwann cells enhances axonal conduction in demyelinated spinal cord. J Neurosci 2001; 21(3):944-950.
208. Barnett SC et al. Identification of a human olfactory ensheathing cell that can effect transplant-mediated remyelination of demyelinated CNS axons. Brain 2000; 123(Pt 8): 1581-1588.
209. Yandava BD, Billinghurst LL, Snyder EY. “Global” cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain. Proc Nat Acad Sci USA 1999; 96(12):7029-7034.
210. Hammang JP, Archer DR, Duncan ID. Myelination following transplantation of EGF-responsive neural stem cells into a myelin-deficient environment. Exp Neurol 1997; 147(1):84-95.
211. Avellana-Adalid V et al. Expansion of rat oligodendrocyte progenitors into proliferative “oligospheres” that retain differentiation potential. J Neurosci Res 1996; 45(5):558-570.
212. Zhang SC, Lipsitz D, Duncan ID. Self-renewing canine oligodendroglial progenitor expanded as oligospheres. J Neurosci Res 1998; 54(2):181-190.
213. Zhang SC et al. Generation of oligodendroglial progenitors from neural stem cells. J Neurocytol 1998; 27(7):475-489.
214. Windrem MS et al. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med 2004; 10(1):93-97.
215. Park KI et al. Global gene and cell replacement strategies via stem cells. Gene Ther 2002; 9(10):613-624.
216. Bizen A et al. Transplantation of mesenchymal stem cells derived from the bone marrow into the demyelinated spinal cord. Int Cong Series 2003; 1252:471-475.
217. Burns A, Byrne EJ, Maurer K. Alzheimer’s disease. Lancet 2002; 360(9327):163-165.
218. Silani V et al. Stem-cell therapy for amyotrophic lateral sclerosis. Lancet 2004; 364(9429):200-202.
219. Wu P et al. Region-specific generation of cholinergic neurones from fetal human neural stem cells grafted in adult rat. Nat Neurosci 2002; 5(12):1271-1278.
220. Snyder EY, Taylor RM, Wolfe JH. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature 1995; 374(6520):367-370.
221. Aboody KS et al. From the cover: neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 2000; 97(23):12846-12851.
222. Benedetti S et al. Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med 2000; 6(4):447-450.
223. Ehtesham M et al. The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res 2002; 62(20):5657-5663.
224. Ehtesham M et al. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 2002; 62(24):7170-7174.
225. Nakamura K et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 2004; 11(14):1155-1164.
226. Gieselmann V et al. Gene therapy: prospects for glycolipid storage diseases. Philos Trans R Soc Lond B Biol Sci 2003; 358(1433):921-925.
227. Meng XL et al. Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouse. J Neurosci Res 2003; 74(2):266-277.
228. Maalouf EF et al. Magnetic resonance imaging of the brain in a cohort of extremely preterm infants. J Pediatr 1999; 135(3):351-357.
229. Counsell SJ et al. Diffusion-weighted imaging of the brain in preterm infants with focal and diffuse white matter abnormality. Pediatrics 2003; 112(1 Pt 1):1-7.
230. Ness JK et al. Perinatal hypoxia-ischemia induces apoptotic and excitotoxic death of periventricular white matter oligodendrocyte progenitors. Dev Neurosci 2001; 23(3):203-208.
231. Li Y et al. Apoptosis and protein expression after focal cerebral ischemia in rat. Brain Res 1997; 765(2):301-312.
232. Li Y, Chopp M. Temporal profile of nestin expression after focal cerebral ischemia in adult rat. Brain Res 1999; 838(1-2):1-10.
233. Lindvall O, McKay R. Brain repair by cell replacement and regeneration. Proc Natl Acad Sci USA 2003; 100(13):7430-7431.
234. Zhao M et al. Evidence for neurogenesis in the adult mammalian substantia nigra. Proc Natl Acad Sci USA 2003; 100(13):7925-7930.
235. Magavi SS, Leavitt BR, Macklis JD. Induction of neurogenesis in the neocortex of adult mice. Nature 2000; 405(6789):951-955.
236. Arvidsson A et al. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 2002; 8(9):963-970.
237. Parent JM et al. Rat forebrain neurogenesis and striatal neuron replacement after focal stroke. Ann Neurol 2002; 52(6):802-813.
238. Teramoto T et al. EGF amplifies the replacement of parvalbumin-expressing striatal interneurones after ischemia. J Clin Invest 2003; 111(8):1125-1132.
239. Nakatomi H et al. Regeneration of hippocampal pyramidal neurones after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 2002; 110(4):429-441.
240. Abe K. Therapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury. J Cereb Blood Flow Metab 2000; 20(10):1393-1408.
241. Liu J et al. Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. J Neurosci 1998; 18(19):7768-7778.
242. Li Y, Chen J, Chopp M. Cell proliferation and differentiation from ependymal, subependymal and choroid plexus cells in response to stroke in rats. J Neurol Sci 2002; 193(2):137-146.
243. Parent JM, Valentin VV, Lowenstein DH. Prolonged seizures increase proliferating neuroblasts in the adult rat subventricular zone-olfactory bulb pathway. J Neurosci 2002; 22(8):3174-3188.
244. Miao N et al. Sonic hedgehog promotes the survival of specific CNS neuron populations and protects these cells from toxic insult In vitro. J Neurosci 1997; 17(15):5891-5899.
245. Craig CG et al. In Vivo Growth Factor Expansion of Endogenous Subependymal Neural Precursor Cell Populations in the Adult Mouse Brain. J Neurosci 1996; 16(8):2649-2658.
246. Kuhn HG et al. Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J Neurosci 1997; 17(15):5820-5829.
247. Taylor RM, Snyder EY. Widespread engraftment of neural progenitor and stem-like cells throughout the mouse brain. Transplant Proc 1997; 29(1-2):845-847.
248. Kokaia M et al. Suppressed epileptogenesis in BDNF mutant mice. Exp Neurol 1995; 133(2):215-224.
249. Sheen VL et al. Neural precursor differentiation following transplantation into neocortex is dependent on intrinsic developmental state and receptor competence. Exp Neurol 1999; 158(1):47-62.
250. Chang A et al. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 2000; 20(17):6404-6412.
251. Smith PM, Blakemore WF. Porcine neural progenitors require commitment to the oligodendrocyte lineage prior to transplantation in order to achieve significant remyelination of demyelinated lesions in the adult CNS. Eur J Neurosci 2000; 12(7):2414-2424.
252. Zhang SC, Ge B, Duncan ID. Adult brain retains the potential to generate oligodendroglial progenitors with extensive myelination capacity. Proc Nat Acad Sci USA 1999; 96(7):4089-4094.
253. Wang L et al. Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture. Exp Hematol 2002; 30(7):831-836.
254. Wang L et al. MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology 2002; 7(2):113-117.
255. Schierle GS et al. Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat Med 1999; 5(1):97-100.
256. Brundin P et al. Improving the survival of grafted dopaminergic neurones: a review over current approaches. Cell Transplant 2000; 9(2):179-195.
257. Emgard M, Blomgren K, Brundin P. Characterisation of cell damage and death in embryonic mesencephalic tissue: a study on ultrastructure, vital stains and protease activity. Neuroscience 2002; 115(4):1177-1187.
258. Emgard M et al. Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue: a role for protease activation. J Neurochem 2003; 86(5):1223-1232.
259. Hagell P, Brundin P. Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease. J Neuropathol Exp Neurol 2001; 60(8):741-752.
260. Hansson O et al. Additive effects of caspase inhibitor and lazaroid on the survival of transplanted rat and human embryonic dopamine neurones. Exp Neurol 2000; 164(1): 102-111.
261. Schierle GS, Brundin P. Excitotoxicity plays a role in the death of tyrosine hydroxylaseimmunopositive nigral neurones cultured in serum-free medium. Exp Neurol 1999; 157(2):338-348.
262. Lindvall O. Parkinson disease. Stem cell transplantation. Lancet, 2001; 358 Suppl:S48.
263. Mangi AA et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003; 9(9):1195-1201.
264. Koc, O.N. and Gerson SL. Akt helps stem cells heal the heart. Nat Med 2003; 9(9): 1109-1110.
265. Chen J et al. Caspase inhibition by Z-VAD increases the survival of grafted bone marrow cells and improves functional outcome after MCAo in rats. J Neurol Sci, 2002. 199(1-2):17-24.
266. Takayama H et al. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson’s disease. Nat Med 1995; 1(1):53-58.
267. Rolletschek A et al. Differentiation of embryonic stem cell-derived dopaminergic neurones is enhanced by survival-promoting factors. Mech Dev 2001; 105(1-2):93-104.
268. Schierle GS et al. Differential effects of Bcl-2 overexpression on fibre outgrowth and survival of embryonic dopaminergic neurones in intracerebral transplants. Eur J Neurosci 1999; 11(9):3073-3081.
269. Ourednik V et al. Neural stem cells—a versatile tool for cell replacement and gene therapy in the central nervous system. Clin Genet 1999; 56(4):267-278.
270. Sabate O et al. Transplantation to the rat brain of human neural progenitors that were genetically modified using adenoviruses. Nat Genet 1995; 9(3):256-260.
271. Sabate O et al. Adenovirus for neurodegenerative diseases: in vivo strategies and ex vivo gene therapy using human neural progenitors. Clin Neurosci 1995; 3(5):317-321.
272. Ourednik J et al. Ectopic expression of the neural cell adhesion molecule L1 in astrocytes leads to changes in the development of the corticospinal tract. Eur J Neurosci 2001; 14(9):1464-1474.
273. Tabbal S, Fahn S, Frucht S. Fetal tissue transplantation in Parkinson’s disease. Curr Opin Neurol 1998; 11(4):341-349.
274. Daadi MM, Weiss S. Generation of tyrosine hydroxylase-producing neurones from precursors of the embryonic and adult forebrain. J Neurosci 1999; 19(11):4484-4497.
275. Teng YD et al. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci USA 2002; 99(5):3024-3029.
276. Gnecchi M et al. Paracrine action accounts for marked protection of ischemic heart by Aktmodified mesenchymal stem cells. Nat Med 2005; 11(4):367-368.
277. Svendsen, C., Adult versus embryonic stem cells: which is the way forward? Trends Neurosci 2000; 23(10):450.
278. The University of Western Australia, School of Anatomy and Human Biology, Teaching Website (http://www.lab.anhb.uwa.edu.au/mb140/CorePages/Connective/Connect.htm#labmucous).